SLC7A11, a potential immunotherapeutic target in lung adenocarcinoma.

MLA

Shan, Qingqing, et al. “SLC7A11, a Potential Immunotherapeutic Target in Lung Adenocarcinoma.” Scientific Reports, vol. 13, no. 1, Oct. 2023, pp. 1–12. EBSCOhost, https://doi.org/10.1038/s41598-023-45284-z.

APA

Shan, Q., Zhang, C., Li, Y., Li, Q., Zhang, Y., Li, X., Shi, J., & Hu, F. (2023). SLC7A11, a potential immunotherapeutic target in lung adenocarcinoma. Scientific Reports, 13(1), 1–12. https://doi.org/10.1038/s41598-023-45284-z

Chicago

Shan, Qingqing, Chi Zhang, Yangke Li, Qunying Li, Yifan Zhang, Xue Li, Junqing Shi, and Fengying Hu. 2023. “SLC7A11, a Potential Immunotherapeutic Target in Lung Adenocarcinoma.” Scientific Reports 13 (1): 1–12. doi:10.1038/s41598-023-45284-z.